Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;13(1):3–10.

Article  PubMed  Google Scholar 

Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45.

PubMed  PubMed Central  Google Scholar 

Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.

Article  PubMed  PubMed Central  Google Scholar 

Mukhtar Y, Galalain A, Yunusa U. A modern overview on diabetes mellitus: a chronic endocrine disorder. Eur J Biol Biotechnol. 2020;5(2):1–4.

Google Scholar 

Whalen K, Miller S, Onge ES. The role of sodium-glucose co-transporter 2 inhibitors in the treatment of type 2 diabetes. Clin Ther. 2015;37(6):1150–66.

Article  PubMed  Google Scholar 

Corder AM, Henry RJ. Carbohydrate-degrading enzymes in germinating wheat. Cereal Chem. 1989;66(5):435–9.

Google Scholar 

Eldor R, DeFronzo RA, Abdul-Ghani M. In vivo actions of peroxisome proliferator–activated receptors: glycemic control, insulin sensitivity, and insulin secretion. Diabetes Care. 2013;36(Supplement_2):S162–74.

Article  PubMed  PubMed Central  Google Scholar 

Chiba S. Molecular mechanism in α-glucosidase and glucoamylase. Biosci Biotechnol Biochem. 1997;61(8):1233–9.

Article  PubMed  Google Scholar 

Wu B, Yan J, Yang J, Xia Y, Li D, Zhang F, Cao H. Extension of the life span by Acarbose: is it mediated by the gut microbiota? Aging Dis. 2022;13(4):1005.

Article  PubMed  PubMed Central  Google Scholar 

Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes. Arch Pharm. 2022;355(5):2100313.

Article  Google Scholar 

Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano [3, 2-c] quinoline derivatives as potential anti-diabetic agents. Bioorg Chem. 2018;77:280–6.

Article  PubMed  Google Scholar 

Lee BH, Lee CC, Wu SC. Ice plant (Mesembryanthemum crystallinum) improves hyperglycaemia and memory impairments in a Wistar rat model of streptozotocin-induced diabetes. J Sci Food Agric. 2014;94(11):2266–73.

Article  PubMed  Google Scholar 

Chinthala Y, Thakur S, Tirunagari S, Chinde S, Domatti AK, Arigari NK, Srinivas KV, Alam S, Jonnala KK, Khan F, Tiwari A. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. Eur J Med Chem. 2015;93:564–73.

Article  PubMed  Google Scholar 

Seul SC. Bioinformatics and Molecular Design Research Center. PreADMET program. 2004. http://preadmet.bmdrc.org.

Noori M, Davoodi A, Iraji A, Dastyafteh N, Khalili M, Asadi M, Mohammadi Khanaposhtani M, Mojtabavi S, Dianatpour M, Faramarzi MA, Larijani B. Design, synthesis, and in silico studies of quinoline-based-benzo [d] imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors. Sci Rep. 2022;12(1):14019.

Article  PubMed  PubMed Central  Google Scholar 

Noori M, Rastak M, Halimi M, Ghomi MK, Mollazadeh M, Mohammadi-Khanaposhtani M, Sayahi MH, Rezaei Z, Mojtabavi S, Faramarzi MA, Larijani B. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno [2, 3-b] quinoline-hydrazones as novel inhibitors for α-glucosidase. Bioorg Chem. 2022;127:105996.

Article  PubMed  Google Scholar 

Taj S, Ahmad M, Ashfaq UA. Exploring of novel 4-hydroxy-2H-benzo [e][1, 2] thiazine-3-carbohydrazide 1, 1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study. Int J Biol Macromol. 2022;207:507–21.

Article  PubMed  Google Scholar 

Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA 1c predicts dyslipidaemia. Int J Clin Exp Med. 2007;7:24–9.

Google Scholar